Pioneering research
OXOLIFE is developing a drug in a specific field were none has been effective to date, acting directly on the endometrium enhancing embryo implantation and increasing Life Birth Rates
The answer to an unmet medical need
Treatments and technology to boost ovulation and maximize embryo quality are constantly improving, but no treatment has yet been developed that addresses the process of implantation, accounting for 50% of pregnancies lost in IVF cycles.
Oxolife’s technology increases embryo implantation and restores ovulation.
